| Serial Number | 97660238 |
| Word Mark | KYVTHREE |
| Filing Date | Wednesday, November 2, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, November 30, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 7, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kyverna Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Emeryville, CA 94608 |
| Event Date | Event Description |
| Thursday, November 30, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, November 30, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Thursday, November 30, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, August 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 16, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 16, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 16, 2023 | ASSIGNED TO EXAMINER |
| Monday, November 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 5, 2022 | NEW APPLICATION ENTERED |